Full Name
CHENG LI YAO
Variants
Cheng, L.-Y.
Cheng, L.Y.
 
Main Affiliation
 
 

Publications

Results 1-10 of 10 (Search time: 0.003 seconds).

Issue DateTitleAuthor(s)
11998Butein, a specific protein tyrosine kinase inhibitorYang, E.-B.; Zhang, K.; Mack, P.; Cheng, L.Y. 
21997Effects of IFN-γ, TNF-α and EGF on the expression of HLA class I antigen and the proliferation of human hepatocellular carcinoma HepG2 cellsWang, D.; Yang, E.; Cheng, L.Y. 
31997Effets of EGF unht growth, DMA synthesis, and receptor intcrnalization in human chan; liver and hepatoma hepg2 cellsCheng, L.Y. ; Yang, F.R.D.; Mack, P.
41994Expression of MHC class I antigen in Morris rat hepatoma and normal liverWang, D.; Yang, E.; Cheng, L.Y. ; Mach, P.
516-Jul-1996Genistein, a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cellsYang, E.-B.; Wang, D.-F.; Mack, P.; Cheng, L.-Y. 
61997Inhibition of egf receptor tyrosine kinask activity by plant polyphenolsYang, E.-B.; Tang, W.-Y.; Cheng, L.-Y. ; Mack, P.
71996Modulation of EGF receptor by tumor necrosis factor-α in human hepatocellular carcinoma HepG2 cellsWang, D.; Yang, E.B.; Cheng, L.Y. 
815-Jul-1997Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survivalYang, E.-B.; Tang, W.-Y.; Zhang, K.; Cheng, L.-Y. ; Mack, P.O.P.
91994Studies of epidermal growth factor (EGF) receptor in plasma membrane from rat liver and hepatoma tissuesYang, E.-B.; Mack, P.; Cheng, L.-Y. 
101997Transmodulation of EGF receptor by interferon-γ in human hepatocellular carcinoma HepG2 cellsWang, D.; Yang, E.B.; Lek, L.H.; Cheng, L.Y.